Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Scudla

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1989
Ultrasonography of primary liver carcinoma (PLC) and targetted cytologic examinationZ Frysák, M Novák, M Dusková, et al.
Neoplasma|September 8, 2011
Analysis of the serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and different stages of multiple myelomaV Scudla, P Petrova, J Minarik, et al.
Vnitrni Lekarstvi|May 1, 1991
[Serum beta 2-microglobulin in multiple myeloma. II. Its significance in monitoring the disease]V Scudla, M Budíková, E Fischerová, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1991
Karyotypic abnormalities and their clinical aspects in multiple myelomaV Scudla, M Jarosová, M Kapustová, et al.
Ceskoslovenska Patologie|February 2, 2011
[Analysis of bone marrow angiogenesis in multiple myeloma]M Tichý, V Tichá, V Scudla, et al.
Vnitrni Lekarstvi|March 1, 1994
[Serum thymidine kinase in multiple myeloma: II. Relation to disease activity and stage]V Scudla, T Papajík, J Bacovský, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|August 16, 2011
[Multiple spinal myeloma and its surgical management]L Hrabálek, J Bacovský, V Scudla, et al.
Casopis Lekaru Ceskych|September 6, 2000
[Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma]V Scudla, M Budíková, J Bacovský, et al.
Ceskoslovenska Patologie|September 7, 2000
[Biological characteristics of multiple myeloma]J Dusek, V Scudla, Z Kolár, et al.
Vnitrni Lekarstvi|August 1, 1993
[Treatment of resistant forms of multiple myeloma using a combination of mitoxantrone, vincristine and prednisone (the NOP regimen)]V Scudla, J Bacovský, L Faltýnek, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1989
Ultrasonography of primary liver carcinoma (PLC) and targetted cytologic examinationZ Frysák, M Novák, M Dusková, et al.
Neoplasma|September 8, 2011
Analysis of the serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and different stages of multiple myelomaV Scudla, P Petrova, J Minarik, et al.
Vnitrni Lekarstvi|May 1, 1991
[Serum beta 2-microglobulin in multiple myeloma. II. Its significance in monitoring the disease]V Scudla, M Budíková, E Fischerová, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1991
Karyotypic abnormalities and their clinical aspects in multiple myelomaV Scudla, M Jarosová, M Kapustová, et al.
Ceskoslovenska Patologie|February 2, 2011
[Analysis of bone marrow angiogenesis in multiple myeloma]M Tichý, V Tichá, V Scudla, et al.
Vnitrni Lekarstvi|March 1, 1994
[Serum thymidine kinase in multiple myeloma: II. Relation to disease activity and stage]V Scudla, T Papajík, J Bacovský, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|August 16, 2011
[Multiple spinal myeloma and its surgical management]L Hrabálek, J Bacovský, V Scudla, et al.
Casopis Lekaru Ceskych|September 6, 2000
[Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma]V Scudla, M Budíková, J Bacovský, et al.
Ceskoslovenska Patologie|September 7, 2000
[Biological characteristics of multiple myeloma]J Dusek, V Scudla, Z Kolár, et al.
Vnitrni Lekarstvi|August 1, 1993
[Treatment of resistant forms of multiple myeloma using a combination of mitoxantrone, vincristine and prednisone (the NOP regimen)]V Scudla, J Bacovský, L Faltýnek, et al.
Pageof 8